表紙
市場調査レポート

腸疾患検査の世界市場:2016〜2020年

Global Enteric Disease Testing Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 295850
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
腸疾患検査の世界市場:2016〜2020年 Global Enteric Disease Testing Market 2016-2020
出版日: 2016年07月20日 ページ情報: 英文 65 Pages
概要

腸疾患は細菌やウイルスによって引き起こされる感染症で、胃痛、嘔吐、下痢、吐き気、食欲不振、熱などの症状があります。腸疾患検査は、即時検査、培養検査、酵素免疫アッセイ検査などを用いて行われます。世界の腸疾患検査市場は、2016〜2020年にかけCAGR8.9%で拡大すると予測されています。

当レポートでは、世界の腸疾患検査市場について調査し、市場の成長見通し、地域別動向、市場の動向と課題、主要ベンダーの競合動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 償還シナリオ:概要

第6章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 臨床診断検査の種類

  • 免疫測定検査
  • 分子診断検査

第8章 腸疾患検査の世界市場:疾患別市場分類

  • 細菌
  • ウイルス

第9章 腸疾患検査の世界市場:地域別分類

  • 地域別分類
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 腸疾患検査の世界市場:促進因子

  • 腸疾患の高い発症率
  • 分子診断検査の導入拡大
  • 新規検査プラットフォームの入手性

第11章 促進因子の影響

第12章 腸疾患検査の世界市場:課題

  • 厳しい法規制環境
  • 途上国の認識不足
  • 熟練技術者の不足

第13章 促進因子と課題の影響

第14章 腸疾患検査の世界市場:動向

第15章 ベンダー環境

  • 競合シナリオ
  • 主要ベンダー分析
  • その他の注目すべきベンダー

第16章 付録

第17章 Technavioについて

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR8514

About Enteric Diseases

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.

Technavio's analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere
  • bioMerieux
  • Cepheid
  • DiaSorin

Other Prominent Vendors

  • BD
  • Biomerica
  • Coris BioConcept
  • Meridian Bioscience
  • Mobidiag
  • Quidel
  • Quest Diagnostics
  • R-Biopharm
  • Trinity Biotech
  • Thermo Fisher Scientific

Market driver

  • Increase in adoption of molecular diagnostic testing
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness in underdeveloped countries
  • For a full, detailed list, view our report

Market trend

  • Shift from singleplex to multiplex testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Reimbursement scenario: An overview

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Types of clinical diagnostic testing

  • Immunoassay testing
  • Molecular diagnostic testing

PART 08: Market segmentation by disease type

  • Bacterial enterics
  • Viral enterics

PART 09: Geographical segmentation

  • Geographical segmentation of global enteric disease testing market 2015-2020
  • Enteric disease testing market in Americas
  • Enteric disease testing market in EMEA
  • Enteric disease testing market in APAC

PART 10: Market drivers

  • High incidence of enteric diseases
  • Increase in adoption of molecular diagnostic testing
  • Availability of novel enteric testing platforms

PART 11: Impact of drivers

PART 12: Market challenges

  • Stringent regulatory environment
  • Lack of awareness in underdeveloped countries
  • Shortage of skilled technicians

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Development of novel NAAT for enteric disease testing
  • Shift from singleplex to multiplex testing

PART 15: Vendor landscape

  • Competitive scenario
  • Key vendor analysis
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Reimbursement perspectives of healthcare entities
  • Exhibit 03: Global enteric disease testing market
  • Exhibit 04: Global enteric disease testing market 2015-2020 ($ millions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Segmentation of global enteric disease testing market by microorganism 2015
  • Exhibit 07: Segmentation of global enteric disease testing market by geography 2015
  • Exhibit 08: Segmentation of global enteric disease testing market by geography 2020
  • Exhibit 09: Segmentation of global enteric disease testing market by geography 2015-2020
  • Exhibit 10: Enteric disease testing market in Americas 2015-2020 ($ millions)
  • Exhibit 11: Enteric disease testing market in EMEA 2015-2020 ($ millions)
  • Exhibit 12: Enteric disease testing market in APAC 2015-2020 ($ millions)
  • Exhibit 13: Impact of drivers
  • Exhibit 14: Impact of drivers and challenges
  • Exhibit 15: Alere: Key takeaways
  • Exhibit 16: bioMerieux: Key takeaways
  • Exhibit 17: Cepheid: Key takeaways
  • Exhibit 18: DiaSorin: Key takeaways
Back to Top